Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure

Jeffrey Gold, Suzanne Cullinane, Jonathan Chen, Susan Seo, Mehmet C. Oz, Juan A. Oliver, Donald W. Landry

Research output: Contribution to journalArticle

55 Scopus citations

Abstract

The use of PDE inhibitors such as milrinone in the treatment of severe heart failure is frequently restricted because they cause vasodilation and hypotension. In patients with decompensated heart failure with hypotension after treatment with milrinone, low doses of vasopressin allowed restoration of blood pressure without inhibiting the inotropic effect of milrinone.

Original languageEnglish (US)
Pages (from-to)506-508
Number of pages3
JournalAmerican Journal of Cardiology
Volume85
Issue number4
DOIs
StatePublished - Feb 15 2000

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure'. Together they form a unique fingerprint.

  • Cite this